HowardKaufmanMD
General Surgery • Boston, MASurgical Oncology (Other than Breast)
Professor of Surgery, Loyola University-Stritch School of Medicine
Dr. Kaufman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Boston, MA 02114Phone+1 617-726-6607
Education & Training
Boston University Medical CenterResidency, Surgery, 1990 - 1995
National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 1988 - 1990
Ascension Illinois/Saint FrancisResidency, Internal Medicine, 1988 - 1988
University of Illinois College of Medicine at ChicagoInternship, Transitional Year, 1986 - 1987
Loyola University Chicago Stritch School of MedicineClass of 1986
Certifications & Licensure
VA State Medical License 1900 - Present
MA State Medical License 1990 - 2025
ME State Medical License 2020 - 2021
NJ State Medical License 2014 - 2017
IL State Medical License 1986 - 2014
NY State Medical License 1997 - 2011
MD State Medical License 1989 - 1998- American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Intratumoral CAVATAK (CVA21) and Pembrolizumab in Patients With Advanced Melanoma (VLA-011 CAPRA) Start of enrollment: 2015 Dec 17
Publications & Presentations
PubMed
- 1283 citationsManaging toxicities associated with immune checkpoint inhibitors: Consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Wor...Igor Puzanov, Adi Diab, K. Abdallah, Clifton O. Bingham, C. Brogdon
Journal for Immunotherapy of Cancer. 2017-11-21 - 438 citationsOncolytic viruses: a new class of immunotherapy drugs.Howard L Kaufman, Frederick J Kohlhapp, Andrew Zloza
Nature Reviews. Drug Discovery. 2015-09-01 - 8 citationsViral Vectors Expressing Interleukin 2 for Cancer Immunotherapy.Hongbin Wang, Mia Borlongan, Akseli Hemminki, Saru Basnet, Naresh Sah
Human Gene Therapy. 2023-09-01
Journal Articles
- Author Correction: Integrating Oncolytic Viruses in Combination Cancer ImmunotherapyHoward Kaufman, MD, Nature
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
